Sunshine Biopharma Stock Forecast - 20 Period Moving Average
| SBFMW Stock | USD 0.08 0.0003 0.36% |
The 20 Period Moving Average forecasted value of Sunshine Biopharma Warrant on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.33. Sunshine Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Sunshine Biopharma stock prices and determine the direction of Sunshine Biopharma Warrant's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Sunshine Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Sunshine Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Sunshine Biopharma's systematic risk associated with finding meaningful patterns of Sunshine Biopharma fundamentals over time.
Check out Historical Fundamental Analysis of Sunshine Biopharma to cross-verify your projections. Sunshine |
Most investors in Sunshine Biopharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Sunshine Biopharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Sunshine Biopharma's price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Sunshine Biopharma Warrant is based on a synthetically constructed Sunshine Biopharmadaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time. Sunshine Biopharma 20 Period Moving Average Price Forecast For the 30th of May
Given 90 days horizon, the 20 Period Moving Average forecasted value of Sunshine Biopharma Warrant on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.33.Please note that although there have been many attempts to predict Sunshine Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sunshine Biopharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sunshine Biopharma Stock Forecast Pattern
| Backtest Sunshine Biopharma | Sunshine Biopharma Price Prediction | Buy or Sell Advice |
Sunshine Biopharma Forecasted Value
In the context of forecasting Sunshine Biopharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sunshine Biopharma's downside and upside margins for the forecasting period are 0.0008 and 23.19, respectively. We have considered Sunshine Biopharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Sunshine Biopharma stock data series using in forecasting. Note that when a statistical model is used to represent Sunshine Biopharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 76.6825 |
| Bias | Arithmetic mean of the errors | -0.017 |
| MAD | Mean absolute deviation | 0.0316 |
| MAPE | Mean absolute percentage error | 0.2951 |
| SAE | Sum of the absolute errors | 1.3291 |
Predictive Modules for Sunshine Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sunshine Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sunshine Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Sunshine Biopharma
For every potential investor in Sunshine, whether a beginner or expert, Sunshine Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sunshine Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sunshine. Basic forecasting techniques help filter out the noise by identifying Sunshine Biopharma's price trends.Sunshine Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sunshine Biopharma stock to make a market-neutral strategy. Peer analysis of Sunshine Biopharma could also be used in its relative valuation, which is a method of valuing Sunshine Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sunshine Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sunshine Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sunshine Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sunshine Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Sunshine Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sunshine Biopharma shares will generate the highest return on investment. By undertsting and applying Sunshine Biopharma stock market strength indicators, traders can identify Sunshine Biopharma Warrant entry and exit signals to maximize returns.
| Accumulation Distribution | 279.6 | |||
| Daily Balance Of Power | 0.0083 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.1 | |||
| Day Typical Price | 0.096 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | 3.0E-4 |
Sunshine Biopharma Risk Indicators
The analysis of Sunshine Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sunshine Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sunshine stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 17.37 | |||
| Semi Deviation | 19.97 | |||
| Standard Deviation | 23.72 | |||
| Variance | 562.82 | |||
| Downside Variance | 625.23 | |||
| Semi Variance | 398.71 | |||
| Expected Short fall | (21.68) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sunshine Biopharma is a strong investment it is important to analyze Sunshine Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sunshine Biopharma's future performance. For an informed investment choice regarding Sunshine Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Sunshine Biopharma to cross-verify your projections. For more information on how to buy Sunshine Stock please use our How to Invest in Sunshine Biopharma guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Sunshine Stock analysis
When running Sunshine Biopharma's price analysis, check to measure Sunshine Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunshine Biopharma is operating at the current time. Most of Sunshine Biopharma's value examination focuses on studying past and present price action to predict the probability of Sunshine Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunshine Biopharma's price. Additionally, you may evaluate how the addition of Sunshine Biopharma to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Sunshine Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.21) | Revenue Per Share 76.716 | Quarterly Revenue Growth 0.541 | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.